Search clinical trials for: Incretins

Total 1746 results

Nagaoka Red Cross Hospital

Unknown

A Cohort Study of Incretin-based Therapy Combined With Insulin in Type 2 Diabetic Patients for 5 Years

Type 2 Diabetes Mellitus

Japan
University of Campania "Luigi Vanvitelli"

Completed

Incretin and CRTd.

Heart Failure | Type 2 Diabetes Mellitus

Italy
Assistance Publique - Hôpitaux de Paris
Assistance Publique Hopitaux De Marseille; Institut National de la Santé Et... and other collaborators

Active, not recruiting

Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy (ANGIOSAFE2)

Type 2 Diabetes

France
Nagaoka Red Cross Hospital

Unknown

Effect of Incretin-related Drugs on Dietary Intake in Japanese Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Hvidovre University Hospital

Completed

Glucose-dependent Insulinotropic Polypeptide (GIP) and Lipid Metabolism

Healthy Subjects

Denmark
University of Sao Paulo General Hospital

Recruiting

L-Cell Activity in Small Intestine as Biliopancreatic Loop in Obese Patients With DM2 Submitted to RYGBP

Type 2 Diabetes Mellitus in Obese | Severe Obesity

Brazil
Albert Einstein College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Merck...

Terminated

Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates

Type 2 Diabetes

United States
Centre Hospitalier Universitaire de Besancon
Eli Lilly and Company; AstraZeneca

Completed

Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients (ExeQOL)

Quality of Life

France
University of Nottingham

Completed

Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal Muscle (Incretin)

Sarcopenia

United Kingdom
Centre Hospitalier Universitaire de Besancon
Eli Lilly and Company; AstraZeneca

Completed

Exenatide for Stress Hyperglycemia (ExSTRESS)

Stress Hyperglycemia

France
Ali Aminian

Not yet recruiting

Fibrosis Lessens After Metabolic Surgery (FLAMES)

Obesity | Liver Fibrosis | Non-Alcoholic Fatty Liver Disease | Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) | Metabolic Dysfunction-Associated Steatohepatitis (MASH)

United States, Sweden, Ireland, Finland, United Kingdom, Spain, Switzerland, Brazil, Canada, Italy, Kuwait, India, Mexico
Johns Hopkins University

Terminated

Glycemia in Diabetic Elders Trial

Type 2 Diabetes Mellitus

United States
University of Campania "Luigi Vanvitelli"

Unknown

Epicardial Fat and Clinical Outcomes After Coronary Artery Bypass Grafting in Diabetics vs. Non Diabetics

Coronary Artery Disease | Diabetes

Italy
Royal North Shore Hospital

Not yet recruiting

Tirzepatide for the Concurrent Treatment of Obesity and Type 1 Diabetes (TZP-T1D)

Obesity | Type 1 Diabetes Mellitus
Eli Lilly and Company

Recruiting

A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes (TREASURE-CKD)

Obesity | Overweight | Type 2 Diabetes | Chronic Kidney Disease | T2D

United States, Mexico, Canada, Austria, Netherlands, Denmark
Temple University
The Comprehensive NeuroAIDS Center (CNAC) at Temple University

Terminated

Liraglutide for HIV-associated Neurocognitive Disorder

HIV Infection | Obesity | Overweight | Metabolic Syndrome | Diabetes Mellitus Type 2

United States
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) in Healthy Lactating Females

Healthy

United States
David Sanchez Garcia
Instituto Mexicano del Seguro Social

Completed

Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Mexico
Novo Nordisk A/S

Withdrawn

INSPIRE Turkey :A Research Study Looking at the Clinical Parameters Associated With Use and Discontinuation of Saxenda® in Local Clinical Practice in Turkey by Analysing Past Patient Medical Records (INSPIRE Turkey)

Obesity

Turkey
Eli Lilly and Company

Recruiting

A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity

Obesity | Type 2 Diabetes

United States, Turkey, Mexico, Argentina, Israel, United Kingdom
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight (SURMOUNT-2)

Obesity | Overweight | Type 2 Diabetes

United States, Russian Federation, Taiwan, Argentina, Brazil, Japan, Puerto Rico, India
Novo Nordisk A/S

Completed

In Market Utilisation of Liraglutide Used for Weight Management in the UK: a Study in the CPRD Primary Care Database

Obesity | Overweight

Denmark
Novo Nordisk A/S

Completed

A Regulatory Post-marketing Surveillance (rPMS) Study to Evaluate the Safety and Effectiveness of Saxenda®(Liraglutide 3.0 mg) in Obese Patients and Overweight Patients With Obesity-related Comorbidities in Routine Clinical Practice in Korea.

Obesity | Overweight

Korea, Republic of
Eli Lilly and Company

Recruiting

A Study of LY3841136 in Overweight and Obese Participants

Obesity | Overweight

United States
University of Virginia
National Institutes of Health (NIH); American Diabetes Association

Recruiting

Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007) (ZQL007)

Type2 Diabetes

United States
Eli Lilly and Company

Active, not recruiting

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity (SURMOUNT-MMO)

Obesity | Overweight

Spain, United States, Australia, Italy, Hungary, India, Israel, Canada, China, Taiwan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Poland, Argentina, Brazil, Puerto Rico, Austria, Turkey, Japan, Netherlands, Korea, Republic... and more
Eli Lilly and Company

Completed

Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea (SURMOUNT-OSA)

Obesity | Sleep Apnea

United States, China, Taiwan, Germany, Mexico, Brazil, Japan, Czechia, Australia, Puerto Rico
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH) (SYNERGY-NASH)

Nonalcoholic Steatohepatitis

United States, Spain, Japan, United Kingdom, Belgium, France, Italy, Israel, Mexico, Poland
Novo Nordisk A/S

Completed

Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With Obesity

Obesity | Metabolism and Nutrition Disorder

United States, Russian Federation, Sweden, Belgium, Mexico
GlaxoSmithKline

Completed

A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.

Diabetes Mellitus, Type 2

United States, South Africa
University at Buffalo
American Diabetes Association

Withdrawn

Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes

Type 1 Diabetes

United States
Novo Nordisk A/S

Completed

Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes (ROOTS)

Diabetes Mellitus, Type 2 | Diabetes

Belgium
Novo Nordisk A/S

Completed

Safety and Tolerability of Liraglutide in Subjects With Impaired Kidney Function and in Subjects With Normal Kidney Function

Diabetes Mellitus, Type 2 | Diabetes

Australia
Novo Nordisk A/S

Completed

Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers

Healthy | Diabetes

Germany
Maastricht University Medical Center

Terminated

GLP-1 and Non-exercise Activity Thermogenesis in RHZ

Type 2 Diabetes Mellitus

Netherlands
Florida Academic Centers Research and Education...

Not yet recruiting

Evaluate the Efficacy of TIRZEPATIDE for the Treatment of Moderate to Severe HS Hidradenitis Suppurativa

Hidradenitis Suppurativa
Eli Lilly and Company

Recruiting

A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Obesity | Overweight

United States, Canada, Italy, Czechia, Israel, Mexico, Poland
Stanford University
Eli Lilly and Company

Not yet recruiting

Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity

Obesity | Overweight | Overweight and Obesity
Second Xiangya Hospital of Central South University

Unknown

Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus

Type 1 Diabetes Mellitus | Autoimmune Diabetes

China
Novo Nordisk A/S

Completed

Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes (SUSTAIN 10)

Diabetes Mellitus, Type 2 | Diabetes

Italy, Spain, United Kingdom, France, Sweden, Finland, Poland, Slovenia, Hungary, Germany, Bulgaria, Czechia
Novo Nordisk A/S

Completed

Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice

Diabetes Mellitus, Type 2 | Diabetes

Italy
Novo Nordisk A/S

Completed

Evaluating the Safety and Effectiveness of Liraglutide in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Japan
Novo Nordisk A/S

Completed

Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®)

Diabetes Mellitus, Type 2 | Diabetes

Japan
Novo Nordisk A/S

Completed

Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2 | Diabetes

Korea, Republic of
Novo Nordisk A/S

Completed

A Trial to Assess the Effect of Liraglutide on Gastric Emptying in Healthy Obese Volunteers

Obesity | Metabolism and Nutrition Disorder

Netherlands
Novo Nordisk A/S

Completed

Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes (EVIDENCE)

Diabetes Mellitus, Type 2 | Diabetes

France
Novo Nordisk A/S

Completed

Comparison of Liraglutide Injected at Three Different Injection Sites in Healthy Volunteers

Healthy | Diabetes

Germany
Novo Nordisk A/S

Completed

Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Japan
Novo Nordisk A/S

Completed

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Denmark, Netherlands, France, Slovakia
Novo Nordisk A/S

Completed

A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India (Lead-In)

Diabetes Mellitus, Type 2 | Diabetes

India

Search clinical trials for: Incretins

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations